Stage FocusSeries B+
GeographyUS
TypeGrowth Equity
Last Activity2026
Industry Focus
Industries
AISemiconductorsNeurotechMobilityEnergy Tech
Technical BenchLimited
Investor TypeGeneralist
ExposureMinimal DeepTech Investments
Bio
Archerman Capital is a growth equity firm founded in 2018, headquartered in Boston with investment teams in New York and San Francisco. It manages $1 billion in AUM and describes its approach as research-driven, with a stated focus on growth-stage companies in AI, data infrastructure, and cybersecurity. The founding partner is Harry Archerman, alongside partners Tyler Flint, Jackson Dean, and Becc...
Similar Funds
Colle Capital
New York, United States
GeneralistAIMedtechIoT & EdgeSeedSeries A
Koch Disruptive Technologies
Wichita, United States
GeneralistAISemiconductorsCybersecuritySeries ASeries B+
LG Technology Ventures
Seoul, South Korea
GeneralistAIAdvanced MaterialsMedtechSeedSeries A
NC
Newfund Capital
Paris, France
GeneralistAINeurotechMedtechPre-SeedSeed
RV
Rosecliff Ventures
New York, United States
GeneralistAISpaceSemiconductorsSeedSeries A
AE
Alpha Edison
Los Angeles, United States
GeneralistAIQuantumAerospaceSeedSeries A